M
MGX
Metagenomi Therapeutics, Inc
1.370
-0.030-2.14%Opening15:01 05/29 EDT
OPEN/PREV CLOSE1.390/1.400
TODAY RANGE1.355-1.400
VOL151.32K
MARKET CAP51.58M
52 WEEK RANGE1.240-3.950
AVG VOL (3M)212.06K
% TURNOVER0.40%
TURNOVER--
P/E (TTM)-0.5966
% RANGE3.21%
EPS(TTM)-2.2965
P/E(FORWARD)-0.6493
P/B0.3743
BVPS3.660
DIVIDEND--
P/S2.044
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP41.65M
SHARES OUTSTANDING37.65M
NEXT EARNINGS08/10-08/14
FREE FLOAT30.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/14 13:33
Analysts Have Lowered Expectations For Metagenomi Therapeutics, Inc. (NASDAQ:MGX) After Its Latest Results
Dow Jones·05/12 13:37
Metagenomi Price Target Cut to $9.00/Share From $12.00 by Wells Fargo
Dow Jones·05/12 13:37
Metagenomi Is Maintained at Overweight by Wells Fargo
TipRanks·05/12 10:38
Wells Fargo Keeps Their Buy Rating on Metagenomi, Inc. (MGX)
TipRanks·05/12 10:27
Metagenomi price target lowered to $9 from $12 at Wells Fargo
Reuters·05/12 07:21
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
TipRanks·05/11 20:47
Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy
TipRanks·05/11 20:36
Metagenomi reports Q1 EPS (61c), consensus (55c)
Reuters·05/11 20:05
METAGENOMI THERAPEUTICS INC - Q1 NET LOSS PER SHARE $0.61
Dow Jones·05/11 20:05
Press Release: Metagenomi Therapeutics Reports -2-
TipRanks·04/16 12:07
Metagenomi announces publication on MG119-28
Same Industry
Name/Symbol
Change%
Price